Navigation Links
Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
Date:4/30/2008

CARLSBAD, Calif., April 30 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the company's participation in the Bank of America 2008 Healthcare Conference scheduled to take place at the Four Seasons Hotel in Las Vegas, Nev., May 13 - 15, 2008.

Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli, COO, will present at the conference on Tuesday, May 13, 2008 beginning at approximately 9:20am PDT. They will provide an overview of the company's specialized diagnostic laboratory service offerings, growth strategies and operational performance.

The presentation is expected to last approximately 40 minutes, followed by a short question and answer session, all of which will be webcast live on the Internet and accessible through the investor relations section of the Genoptix website at http://www.genoptix.com. Listeners should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix dis
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
2. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
3. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
4. Genoptix Announces Pricing of Secondary Public Offering
5. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
6. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
7. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
8. Genoptix, Inc. Announces Pricing for Initial Public Offering
9. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
10. ATS Medical Announces First Frontiers in Cryoablation Symposium
11. Carriage Services Announces First Quarter Earnings Release and Conference Call Schedule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...hts positive influence of sports participation on ...L (Vocus) November 9, 2009 -- As people age fractu...earch has highlighted the importance of exercise a...s. However, a new study published in the November/...ary Approach reveals that there may be significan...
(Date:11/9/2009)...ighting a commitment to providing long-term health...digital display technology options, LG Electronics...tal Grade LCD HDTVs this week at the Association o...ting and exposition (booth #1760). ,, On displa...Long-Term Care LCD HDTVs bring a sense of home awa...
(Date:11/9/2009)...Phoenix House , the nation,s leading non-profit a...gram, announced today its appointment of Deni Cari...ized leader in substance abuse treatment and resea...1, 2010. ,, "Dr. Deni Carise is at the very f... her work has resulted in a significant transforma...
(Date:11/9/2009)...edure for Preteen Son - ,, PHILADELPHIA, Nov....ren with cancer, the hopeful news is that pediatri...s. Among the bad news -- treatments that enable su...osed with cancer who have reached puberty currentl... before undergoing cancer treatment, they may have...
(Date:11/9/2009)... the University of Florida Proton Therapy Institut...erapy for St. Jude patients. The announcement foll...aluate the use of proton therapy for rare brain ca...Under the clinical protocol, St. Jude will refer p... Therapy Institute in Jacksonville, Fla. The purpo...
Breaking Medicine News(10 mins):Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2
...Tool Gives Anthem Members in six California, coun...eo, San Francisco, Santa Clara, the Most Complete... Procedures, WOODLAND HILLS,...pproximately 1.8 million of,Anthem Blue Cross memb...
...oal of developing reliable genetic tests to guide ...searchers at Columbia University recently evaluate...or signatures, to predict the likelihood that canc...Thoracic Societys 2008 International Conference in...
...y 19 Towards the Electronic,Patient Record (TEPR)...ogy,announced today its next-generation interface ...ients using IMO-enhanced terminologies access to a...ghly,scalable and redundant environment. The Termi...
...ld Against Mesothelioma Victim,s Former Employers,...ter,winning a $3.2 million verdict against contrac...c. and Jacobs Constructors, Inc. on behalf of,meso...ormer welder and pipefitter, contracted mesothelio...
... at the University of Liverpool has performed a gr...orrect a deformity more commonly seen in dogs. , ...from the Cameroon pet trade last year and now live...arm - the ulna - had stopped growing. , It is tho...
...ew Delhi and Singapore (May 14, 2008) SAGE, the w...unced its continued expansion in medical publishin...iabetes & Vascular Disease and Journal of the Reni...p between diabetes and other metabolic diseases an...
Other Medicine News:Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 2Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 3Health News:Will lung cancer recur? A genetic test may provide the answer 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd 2Health News:Surgeon operates to rescue chimp with rare deformity 2Health News:SAGE acquires 2 new medical journals 2
(Date:11/7/2009)...ACH, Fla., Nov. 7 Most patients wi...toms that signal an oncoming HAE attack giving the...d decrease the morbidity associated with that atta...t the 2009 American College of Allergy, Asthma &am...ition of symptoms such as fatigue and nausea, whic...
(Date:11/6/2009)...N.C., Nov. 6 Oxygen Biot... announced that a previously approved reverse spli...t of trading on Monday, Nov. 9, 2009 on a 1-for-15.... shares will trade under the new symbol OXBT. The...0 9, when the split becomes effective. ,, "This...
(Date:11/6/2009)..., FORT WASHINGTON, Pa., Nov. 6 In ...ation (FDA), McNeil Consumer Healthcare, Division ...all of a limited number of product lots of TYLENOL...th the distinctive red EZ-OPEN CAP. McNeil is init...istic smell or taste associated with these lots th...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Craneware Announces Fiscal Year End Results 56424 1Craneware Announces Fiscal Year End Results 56424 2Craneware Announces Fiscal Year End Results 56424 3Invision Sally Jobe Names Breast Network Medical Director 56421 1Invision Sally Jobe Names Breast Network Medical Director 56421 2Cancer Drug May Fight Alzheimers 56418 1
...for Sept. 29, LA JOLLA, Calif., June 30 TorreyPi...nced that data presented at the 50th Annual,Scient...ed that, in,addition to meeting the primary endpoi...ny,s lead AMPA/kainate-type glutamate receptor ant...portant secondary endpoints in a,306-patient Phase...
...s Corporation (Nasdaq: UTHR ) and its wholly-owne...bmission of a New Drug Application,(NDA) to the U....g approval,of an inhaled formulation of treprostin...hypertension (PAH), a chronic, life-threatening di...g which the FDA will examine the,application for c...
Other Medicine Technology:Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 2New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 3New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: